ctrl K

AI Score

Unlock

Inozyme Pharma Inc. (INZY)

AI Score

Unlock

1.20

0.00 (0.00%)

At close: Feb 28, 2025, 3:59 PM

1.23

2.93%

After-hours: Feb 28, 2025, 05:00 PM EST

Inozyme Pharma Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.29M	1.18M	1.05M	217K	83K	26K
Gross Profit	-1.29M	-1.18M	-1.05M	-217K	-83K	-26K
Operating Income	-75.64M	-68.67M	-56.65M	-57.04M	-20.81M	-11.59M
Interest Income	7.84M	1.93M	211K	370K	1.11M	284K
Pretax Income	-71.17M	-67.06M	-56.62M	-56.42M	-19.72M	-6.96M
Net Income	-71.17M	-65.45M	-56.41M	-55.84M	-18.62M	-6.96M
Selling & General & Admin	20.8M	20.83M	18.93M	10.55M	4.59M	3.49M
Research & Development	54.05M	47.85M	37.72M	46.49M	16.22M	8.1M
Other Expenses	n/a	-319K	-189K	247K	-24K	4.34M
Operating Expenses	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Interest Expense	3.33M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Income Tax	n/a	-1.61M	-211K	-587K	-1.11M	4.63M
Shares Outstanding (Basic)	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
Shares Outstanding (Diluted)	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
EPS (Basic)	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EPS (Diluted)	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EBITDA	-74.81M	-65.88M	-55.97M	-56.82M	-20.72M	-11.57M
Depreciation & Amortization	833K	1.18M	1.05M	217K	83K	26K